BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25196155)

  • 1. Neuroprotection for ischaemic stroke: current status and challenges.
    Moretti A; Ferrari F; Villa RF
    Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
    Wahlgren NG; Ahmed N
    Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Past, present and future of neuroprotection].
    Mracek J
    Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The past and future of neuroprotection in cerebral ischaemic stroke.
    Shuaib A; Hussain MS
    Eur Neurol; 2008; 59(1-2):4-14. PubMed ID: 17917451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral ischemia--challenges and perspectives].
    Baron JC
    Therapie; 2002; 57(6):531-9. PubMed ID: 12666260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.
    Timsit S; Menn B
    Clin Pharmacol Ther; 2012 Feb; 91(2):327-32. PubMed ID: 22218073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention.
    Broussalis E; Killer M; McCoy M; Harrer A; Trinka E; Kraus J
    Drug Discov Today; 2012 Apr; 17(7-8):296-309. PubMed ID: 22134007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection and neurosupplementation in ischaemic brain.
    Yamashita T; Deguchi K; Sawamoto K; Okano H; Kamiya T; Abe K
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1310-2. PubMed ID: 17073809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral ischaemia: tomorrow's therapeutic tracks].
    Bordet R; Ouk T; Onténiente B; Charriaut-Marlangue C; Heurteaux C
    Med Sci (Paris); 2009 Oct; 25(10):847-54. PubMed ID: 19849988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroprotection in brain ischemia--doubts and hopes].
    Zádor Z; Benyó Z; Lacza Z; Hortobágyi T; Harkány T; Hortobágyi T
    Ideggyogy Sz; 2004 Mar; 57(3-4):81-93. PubMed ID: 15133909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection in acute ischaemic stroke. II: Clinical potential.
    Davis M; Barer D
    Vasc Med; 1999; 4(3):149-63. PubMed ID: 10512595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use before and after acute ischemic stroke onset improves neurological outcome.
    Salat D; Ribosa R; Garcia-Bonilla L; Montaner J
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1219-30. PubMed ID: 19814665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
    Bordet R; Ouk T; Petrault O; Gelé P; Gautier S; Laprais M; Deplanque D; Duriez P; Staels B; Fruchart JC; Bastide M
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1341-6. PubMed ID: 17073815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.